Drug Transporters

We recently ran an industry survey to help us understand what the current industry standards are for when and why...

Highlights from the recent webinar presented by our newest expert consultant, Dr. Pallavi Limaye In her recent webinar (now available for...

In its most recent in vitro drug interaction guidance update, the US Food and Drug Administration (FDA) emphasized harmony with the...

1. Collect high-quality data to make informed, confident go/no go decisions for moving your drug candidate forward If you need...

Systemic clearance, denoting how much drug is cleared from a volume of blood per unit of time, is of critical...

Beyond the need for evidence that a drug works, Food and Drug Administration (FDA) and other regulatory bodies around the...

Though there is no ‘roadmap’ spelling out required studies to achieve regulatory approval for clinical entry, a drug candidate’s metabolism...

Test systems for DMPK in vitro studies are part of the very foundation of our company. Our labs were borne of...

Generally, a drug’s effects on enzyme and transporter activity are examined independently in a drug development program, but what if...

We’re pleased to announce that our scientists’ ongoing dedication to enhancing our processes and discovering new efficiencies without sacrificing quality...